Stockreport

Anavex's Publication Supports Clinical Biomarker For ANAVEX®2-73 In Fragile X Syndrome [TheStreet.com]

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data
PDF NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing [Read more]